First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer

15 Apr 20264 min read0 viewsJournal Feed

GIST

New England Journal of Medicine, Volume 394, Issue 17 , Page 1675-1684, April 30, 2026.

Clinical Editorial

Summary

New England Journal of Medicine published a clinical update in Research Highlights on 15 Apr 2026. The item focuses on First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer. Open the detail page to review the full original feed content.